Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Mimedx Group Inc (NASDAQ: MDXG) closed at $7.20 in the last session, down -1.23% from day before closing price of $7.29. In other words, the price has decreased by -$1.23 from its previous closing price. On the day, 0.67 million shares were traded. MDXG stock price reached its highest trading level at $7.31 during the session, while it also had its lowest trading level at $7.19.
Ratios:
We take a closer look at MDXG’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 21.92 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 32.01. For the most recent quarter (mrq), Quick Ratio is recorded 2.71 and its Current Ratio is at 3.29. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on March 07, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On October 27, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $12.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $7.Mizuho initiated its Buy rating on October 13, 2022, with a $7 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 13 ’24 when Hulse William Frank IV sold 20,381 shares for $7.95 per share. The transaction valued at 162,029 led to the insider holds 479,959 shares of the business.
Whitlow Ricci S sold 15,271 shares of MDXG for $122,351 on Feb 20 ’24. The Chief Operating Officer now owns 401,050 shares after completing the transaction at $8.01 per share. On Feb 16 ’24, another insider, Whitlow Ricci S, who serves as the Chief Operating Officer of the company, sold 15,493 shares for $8.07 each. As a result, the insider received 125,075 and left with 416,321 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDXG now has a Market Capitalization of 1062748800 and an Enterprise Value of 1046998848. As of this moment, Mimedx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.50, and their Forward P/E ratio for the next fiscal year is 17.35. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.03. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.18 while its Price-to-Book (P/B) ratio in mrq is 6.82. Its current Enterprise Value per Revenue stands at 3.13 whereas that against EBITDA is 19.397.
Stock Price History:
Over the past 52 weeks, MDXG has reached a high of $9.27, while it has fallen to a 52-week low of $5.47. The 50-Day Moving Average of the stock is -1.59%, while the 200-Day Moving Average is calculated to be -4.32%.
Shares Statistics:
According to the various share statistics, MDXG traded on average about 872.27K shares per day over the past 3-months and 1038510 shares per day over the past 10 days. A total of 146.23M shares are outstanding, with a floating share count of 113.48M. Insiders hold about 23.12% of the company’s shares, while institutions hold 41.41% stake in the company. Shares short for MDXG as of 1713139200 were 5507139 with a Short Ratio of 6.31, compared to 1710460800 on 5522044. Therefore, it implies a Short% of Shares Outstanding of 5507139 and a Short% of Float of 4.66.
